Mangalam Drugs and Organics Limited (the Company) is engaged in the business of manufacturing of various APIs for anti-malaria, anti-retrovirals etc, including Hydroxrychloroquine Sulphate (HCQS) and Chloroquine Phosphate (CQP) APIs.
The Company is gearing up production of HCQS and CQP APIs to meet the demand in case these APIs are approved for treatnent of patients affected by Coronavirus Disease (COVID-19) by regulatory authorities and safeguard lives of affected in these challenging times.
Shares of MANGALAM DRUGS & ORGANICS LTD. was last trading in BSE at Rs.21.75 as compared to the previous close of Rs. 20.75. The total number of shares traded during the day was 1508 in over 5 trades.
The stock hit an intraday high of Rs. 21.75 and intraday low of 21.75. The net turnover during the day was Rs. 32799.